Ashley Vo
Adjunct Assistant ProfessorÂÂ
Clinical Pharmacy
University of Southern California
United States of America
Biography
"Ashley A. Vo, PharmD, is the Administrative Director of the Transplant Immunotherapy Program at the Comprehensive Transplant Center at Cedars-Sinai Medical Center in Los Angeles, California and Professor of Pediatrics at the David Geffen School of Medicine at UCLA. Dr. Vo earned her Doctor of Pharmacy degree at the University of Southern California in Los Angeles. She completed a General Practice Residency and a Specialty Residency in Administration, both at Cedars-Sinai Medical Center. In addition to teaching, Dr. Vo also conducts clinical research sponsored by Industry and Investigator Initiated trials. Her research has been in advancing the field of desensitization for the highly HLA sensitized patients awaiting kidney transplantation. Dr. Vo serves as an ad hoc reviewer for Transplantation, American Journal of Transplantation, Journal of Immunology, etc. and has published in journals including Transplantation, American Journal of Transplantation, World Journal of Nephrology, and Immunotherapy. Dr. Vo was awarded AST Clinician of Distinction in 2014 and Fellow of the American Society of Transplant in 2016."
Research Interest
Cost effectiveness therapies in management of HLA sensitized patients, desensitization strategies for HLA sensitized patients awaiting renal transplantation
Publications
-
Vo AA, Sinha A, Haas M, Choi J, Mirocha J, Kahwaji J, Peng A, Villicana R, Jordan SC. Factors predicting risk for antibody-mediated rejection and graft loss in highly human leukocyte antigen sensitized patients transplanted after desensitization. Transplantation. 2015 Jul 1;99(7):1423-30.
-
Jordan SC, Choi J, Vo A. Achieving incompatible transplantation through desensitization: current perspectives and future directions.
-
Jordan SC, Choi J, Vo A. Kidney transplantation in highly sensitized patients. British medical bulletin. 2015 May 1;114(1):113-25.